Structure-activity relationship of a novel family of cysteinyl leukotriene receptor antagonist quinoline compounds with anti-angiogenic activity

File(s)
FileDescriptionSizeFormat
Download Pharmacology_2016_vol16issue1abst200p.pdf15.13 KB
Author(s)
Uri
Date Issued
01 April 2017
Date Available
09T13:09:19Z November 2021
Abstract
Introduction: Previously, we identified quininib (2-[(E)-2-(quinolin-2-yl)vinyl]phenol), a cysteinyl leukotriene receptor antagonist with anti-angiogenic and anti-permeable activity (1,2). Here, we report a structure activity relationship study to more comprehensively characterise features which confer anti-angiogenic activity.
Type of Material
Conference Publication
Publisher
British Pharmacological Society
Journal
pA2 Online
Volume
16
Issue
1
Keywords
Web versions
Language
English
Status of Item
Peer reviewed
Description
Pharacology 2016, London, United Kingdom, 13-15 December 2016
ISSN
1741-1157
This item is made available under a Creative Commons License
Owning collection
Veterinary Medicine Research Collection